Page last updated: 2024-08-21

perfluoropentane and B16 Melanoma

perfluoropentane has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, L; Liu, M; Liu, Y; Sheng, D; Song, J; Wang, Z; Wu, M; Yang, Z; Yi, H; Zhang, L; Zhang, N; Zheng, Y	1

Other Studies

1 other study(ies) available for perfluoropentane and B16 Melanoma

Article	Year
Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma. Journal of controlled release : official journal of the Controlled Release Society, 2019, 07-28, Volume: 306 Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Delivery Systems; Female; Fluorocarbons; Immunotherapy; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Oligopeptides; Phototherapy; Programmed Cell Death 1 Receptor; Tumor Microenvironment	2019

Article

Year

Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.

Journal of controlled release : official journal of the Controlled Release Society, 2019, 07-28, Volume: 306

Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Delivery Systems; Female; Fluorocarbons; Immunotherapy; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Oligopeptides; Phototherapy; Programmed Cell Death 1 Receptor; Tumor Microenvironment

2019